BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29797309)

  • 1. Eosinophilic fasciitis and lichen sclerosus in a patient treated with nivolumab.
    Andrés-Lencina JJ; Burillo-Martínez S; Aragón-Miguel R; Calleja-Algarra A; Rodríguez-Peralto JL; Ortiz-Romero PL; Gargallo-Moneva V
    Australas J Dermatol; 2018 Nov; 59(4):e302-e304. PubMed ID: 29797309
    [No Abstract]   [Full Text] [Related]  

  • 2. Nivolumab-associated extragenital lichen sclerosus et atrophicus.
    di Meo N; Conforti C; Corneli P; Vezzoni R; Retrosi C; Pizzichetta MA; Rizzi GM; Zalaudek I
    Clin Exp Dermatol; 2020 Apr; 45(3):350-352. PubMed ID: 31498907
    [No Abstract]   [Full Text] [Related]  

  • 3. Nivolumab-induced multiple morphea associated with eosinophilic fasciitis.
    Lacombe M; Bedane C; Delaumenie S; Bernard P
    Eur J Dermatol; 2021 Dec; 31(6):844-846. PubMed ID: 34911674
    [No Abstract]   [Full Text] [Related]  

  • 4. An unusual skin reaction in uveal melanoma during treatment with nivolumab: extragenital lichen sclerosus.
    Veronesi G; Scarfì F; Misciali C; Tartari F; Melotti B; Patrizi A; Dika E
    Anticancer Drugs; 2019 Oct; 30(9):969-972. PubMed ID: 31205068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lichen sclerosus et atrophicus induced by carbamazepine: a case report.
    Pranteda G; Muscianese M; Grimaldi M; Fidanza L; Pranteda G; Narcisi A; Nistico S; Bottoni U
    Int J Immunopathol Pharmacol; 2013; 26(3):791-4. PubMed ID: 24067479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple erosive lichen planus preceded by solitary lichen planus after combination therapy with nivolumab and radiation.
    Komori T; Honda T; Irie H; Otsuka A; Kabashima K
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):e382-e384. PubMed ID: 28295693
    [No Abstract]   [Full Text] [Related]  

  • 7. Generalized Lichen Nitidus Following Anti-PD-1 Antibody Treatment.
    Cho M; Nonomura Y; Kaku Y; Dainichi T; Otsuka A; Kabashima K
    JAMA Dermatol; 2018 Mar; 154(3):367-369. PubMed ID: 29344609
    [No Abstract]   [Full Text] [Related]  

  • 8. An Original Case of an Association of Eosinophilic Fasciitis with Cholangitis Induced by Nivolumab.
    Le Tallec E; Ricordel C; Triquet L; Deniel A; Marcorelles P; Lena H; Jego P; Belhomme N
    J Thorac Oncol; 2019 Jan; 14(1):e13-e15. PubMed ID: 30579548
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lichen sclerosus atrophicus at an insulin injection site: an unusual koebner phenomenon].
    Monteagudo B; Cabanillas M; Bellido D; Suárez-Amor O; Ramírez-Santos A; de la Cruz A
    Actas Dermosifiliogr; 2010 Jul; 101(6):563-5. PubMed ID: 20738983
    [No Abstract]   [Full Text] [Related]  

  • 10. Disseminated erythema with intense and selective inflammation of sweat gland and lichenoid drug eruption during nivolumab therapy.
    Matsumoto Y; Kadono T; Matsuoka M; Kawakami T; Furuya N; Doi M; Hoshikawa M; Soma Y
    J Dermatol; 2018 Feb; 45(2):e33-e34. PubMed ID: 28984022
    [No Abstract]   [Full Text] [Related]  

  • 11. Checkpoint inhibitor-induced eosinophilic fasciitis following high eosinophilia associated with complete response.
    Toussaint F; Hammon M; Erdmann M; Moreira A; Kirchberger MC; Schuler G; Schett G; Heinzerling L
    Rheumatology (Oxford); 2019 Oct; 58(10):1875-1877. PubMed ID: 31056673
    [No Abstract]   [Full Text] [Related]  

  • 12. Eruptive keratoacanthomas secondary to nivolumab immunotherapy.
    Bednarek R; Marks K; Lin G
    Int J Dermatol; 2018 Mar; 57(3):e28-e29. PubMed ID: 29318617
    [No Abstract]   [Full Text] [Related]  

  • 13. Eruptive keratoacanthomas arising in the setting of lichenoid toxicity after programmed cell death 1 inhibition with nivolumab.
    Feldstein SI; Patel F; Larsen L; Kim E; Hwang S; Fung MA
    J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):e58-e59. PubMed ID: 28776778
    [No Abstract]   [Full Text] [Related]  

  • 14. Eczematous reactions mimicking psoriasiform dermatitis induced by nivolumab for advanced lung cancer.
    Tanaka M; Hoashi T; Ichiyama S; Noro R; Seike M; Kubota K; Gemma A; Funasaka Y; Saeki H
    Australas J Dermatol; 2019 Feb; 60(1):e67-e68. PubMed ID: 29896926
    [No Abstract]   [Full Text] [Related]  

  • 15. Nivolumab PD-1 inhibitor immunotherapy associated with vulvar, perineal and perianal lichen sclerosus.
    Wernham AGH; Shah F; Velangi S
    Clin Exp Dermatol; 2019 Mar; 44(2):e22-e23. PubMed ID: 30430637
    [No Abstract]   [Full Text] [Related]  

  • 16. Histologically-diagnosed psoriasiform dermatitis induced by nivolumab successfully controlled by etanercept: A case report.
    Kim YE; Kim TM; Jo SJ
    J Dermatol; 2019 Dec; 46(12):e464-e466. PubMed ID: 31531885
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical presentations of eosinophilic fasciitis.
    Ergun T; Seckin D; Salman A; Ocak ES; Yucelten AD; Direskeneli H; Demirkesen C; Ekinci G; Bayik M
    Indian J Dermatol Venereol Leprol; 2016; 82(1):47-52. PubMed ID: 26728810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous sclerosis with fasciitis and eosinophilia after phytonadione injections.
    Janin-Mercier A; Mosser C; Souteyrand P; Bourges M
    Arch Dermatol; 1985 Nov; 121(11):1421-3. PubMed ID: 2932062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genital lichen sclerosus after nivolumab.
    Miraglia E; Soda G; Giustini S
    Dermatol Online J; 2020 Nov; 26(11):. PubMed ID: 33342187
    [No Abstract]   [Full Text] [Related]  

  • 20. Diffuse hair loss following anti-programmed cell death-1 antibody treatment: a case report with immunohistochemical analysis.
    Komatsu-Fujii T; Otsuka A; Ishida Y; Kaku Y; Yamashita C; Hata A; Kataoka T; Honda T; Kabashima K
    Eur J Dermatol; 2019 Jun; 29(3):326-327. PubMed ID: 31389791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.